Functional Assessment Protocol for the Upper Limb for Pediatric Age
Launched by IRCCS EUGENIO MEDEA · May 3, 2024
Trial Information
Current as of July 23, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is designed to assess how well children can move their arms and hands during specific tasks. By using special markers placed on the skin, trained therapists will observe and record the movements of participants as they perform certain activities with their upper limbs. The goal is to better understand the range of motion and functionality in both healthy children and those with specific conditions affecting their upper limbs.
To be eligible for this study, healthy children must not have any issues with their arm movements, while children with certain conditions, like brain injuries or those who need specific therapy (called Constraint Induced Movement Therapy), can participate if they can understand and follow instructions. Participants will engage in several trials during each session, and the study is currently looking for volunteers. This research is important for developing better treatments and therapies for children with upper limb challenges.
Gender
ALL
Eligibility criteria
- For healthy group:
- Inclusion Criteria:
- • - absence of functional impairments in the upper limbs
- Exclusion Criteria:
- • behavioral, visual or auditory problems
- • presence of pain in the upper limbs
- For pathological group:
- Inclusion Criteria:
- • Unilateral PCI candidates for CIMT (Constraint Induced Movement Therapy) treatment;
- • Acquired brain injury candidates for CIMT or Bimanual treatment;
- • Ability to understand and follow test instructions.
- Exclusion Criteria:
- • behavioral, visual or auditory problems
- • presence of pain in the upper limbs
About Irccs Eugenio Medea
IRCCS Eugenio Medea is a leading clinical research institute based in Italy, dedicated to advancing pediatric healthcare through innovative research and evidence-based practices. As a recognized center of excellence, it focuses on multidisciplinary approaches to address complex health challenges in children and adolescents, particularly in the fields of neurodevelopmental disorders, mental health, and rehabilitation. The institute collaborates with national and international partners to conduct rigorous clinical trials, aiming to translate scientific discoveries into effective therapeutic interventions. Committed to enhancing patient outcomes, IRCCS Eugenio Medea prioritizes ethical standards and patient safety in all its research endeavors.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Bosisio Parini, Lecco, Italy
Patients applied
Trial Officials
Giuseppe Andreoni
Principal Investigator
IRCCS E. Medea - La Nostra Famiglia
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported